Tuesday, 25 July 2017

Grow Fit closes Series A funding of USD $4.5 million from Manipal Education and Medical Group

21 June 2017 | News

Dr. Ranjan Pai, CEO and MD of MEMG will join the board of directors

Grow Fit announced USD $4.5 million in Series A funding led by MEMG (Manipal Education and Medical Group), the PE arm of the Manipal Group. With this, Dr. Ranjan Pai, the MD & CEO of MEMG will be joining the board of directors.

With an aim of helping over 300 million Indians who are at risk of contracting lifestyle disease, Grow Fit offers a comprehensive approach combining expert coaching, health foods and behavioral insights through their scalable technology platform

Jyotsna Pattabiraman, founder and CEO at Grow Fit said, “Grow Fit combines data science, medical science and behavioural insights to help people achieve their health goals and live their best lives. We are an outcome-oriented company and have always stressed a science-and-data approach. I am delighted that leading professionals from the Manipal Hospital have validated our approach. Grow Fit now has the backing of one of the top medical groups in the country and we are excited about the next phase of growth with this investment."

K Ganesh, Partner, Growth Story, the entrepreneurship platform that promotes high-potential ventures including Grow Fit said: “Companies which have the right genes can always raise funding, even in a somewhat tight market. Grow Fit’s laser-like focus on customer outcomes sets it apart from others. It takes a unique dedication to go against the conventional wisdom of transactions and the team at Grow Fit has demonstrated this commitment time and again."

Dr. Ranjan Pai, CEO and MD, MEMG said, “Grow Fit has the right approach to reach the millions of Indians who can benefit from better nutrition and coaching. I was impressed by their novel approach, their investment in R&D and their technology platform. Indians need to make drastic changes to their health habits and Grow Fit makes it effortless for them. This is a huge opportunity and we are looking forward to unlocking it."

Kris Gopalakrishnan, Co-Founder, Infosys and an early investor in Grow Fit, commented, “Grow Fit has the ability to address both national and international markets. As prosperity increases globally, our nutritional habits have to compensate for our sedentary lifestyle and dependence on fast foods. Grow Fit has a relevant model that could address this gap and be effective anywhere in the world.”

This investment comes at a time when countries the world over are grappling with healthcare costs. According to the World Economic Forum, in India alone, over six million lives are lost every year due to lifestyle diseases and the economic burden of lifestyle diseases has been estimated to be over $4.58 trillion by 2030.

 

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Is digitalisation a global challenge for Indian pharma companies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls